Metabolic dysfunction-associated fatty liver disease (MAFLD) and viral hepatitis due to chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection are common liver diseases worldwide. Excessive alcohol consumption and alcoholic liver disease (ALD) are also emerging health problems. Therefore, in clinical practice, we may encounter subjects with dual etiology of liver diseases such as coexisting MAFLD/HBV, MAFLD/HCV, and MAFLD/ALD. In this review, we summarize the epidemiology, clinical features, and mutual interactions of MAFLD with coexisting HBV, HCV, or ALD. The impact of MAFLD on the progression of liver diseases and treatment outcomes in patients with chronic viral hepatitis and the clinical questions to be addressed regarding dual MAFLD and ALD are also discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12072-024-10699-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- The report updates the 1999 CDC Framework for Program Evaluation in Public Health to include new advancements and lessons learned in evaluation and public health.
- The 2024 framework introduces a nonprescriptive tool with six steps for effective evaluation planning and implementation, while emphasizing engagement, equity, and learning from insights.
- It serves as a guide for designing evaluations applicable to various programs, enhancing evidence-based decision-making, and improving program outcomes across different areas.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!